Failures in sickle-cell therapy, CRO mergers in Asia, Praxis IPO, and wasp venom.

Sponsors

https://www.thescopemethod.com

Story References

https://ir.cyclerion.com/news-releases/news-release-details/cyclerion-announces-phase-2-strong-scd-study-results-patients

https://ir.cyclerion.com/news-releases/news-release-details/cyclerion-announces-positive-data-iw-6463-cns-translational

https://novotech-cro.com/news/asia-pacific-has-record-year-clinical-trials-according-novotech 

https://investors.praxismedicines.com/press-releases

https://www.pnas.org/content/early/2020/10/07/2012379117

Music by Luke Goodson

https://www.soundcloud.com/lukegoodson

 The Niche Podcast brings you interviews with industry experts top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.